The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIXH.L Regulatory News (SIXH)

  • There is currently no data for SIXH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: The 600 Group (SIXH): Acquisition of CMS attractive and EPS-enhancing

2 Jul 2019 10:30

Hardman & Co Research Hardman & Co Research: The 600 Group (SIXH): Acquisition of CMS attractive and EPS-enhancing 02-Jul-2019 / 10:30 GMT/BST


Hardman & Co Research: Acquisition of CMS attractive and EPS-enhancing

The Control Micro Systems Inc (CMS) acquisition (US) is strategically attractive. Trading remains good, with a healthy and improved order book, and growth enhanced by new product launches and new market entry. The group remains competitively well positioned, with a world-class reputation in machine tools and laser marking. The shares stand at a discount to the peer group and to a DCF valuation, and offer an appealing yield.

Please click here for the full report:

https://www.hardmanandco.com/research/corporate-research/acquisition-of-cms-attractive-and-eps-enhancing/

To contact us: Hardman & Co 35 New Broad Street London EC2M 1NH www.hardmanandco.com Follow us on Twitter @HardmanandCo Contacts: Paul Singer +44 20 7194 7622 ps@hardmanandco.com

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

834667 02-Jul-2019 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
3rd Apr 20247:00 amRNSCancellation - 600 GROUP PLC
20th Mar 202411:36 amRNSReplacement: Trading Update & Annual Report Update
19th Mar 20245:15 pmRNSTrading Update and Update regarding Annual Report
7th Feb 20243:30 pmRNSTrading Update and Update regarding Annual Report
2nd Jan 20247:00 amRNSDirectorate Change
7th Dec 20232:36 pmRNSFurther re Debt Facilities
4th Dec 20237:00 amRNSFurther re LOI and Bank Facilities
16th Nov 20234:00 pmRNSChange of Nominated Adviser and Broker
31st Oct 202312:30 pmRNSBoard Changes & Update re Annual Report
6th Oct 20237:00 amRNSLetter of Intent re Potential Disposal
2nd Oct 20237:30 amRNSSuspension - 600 Group plc
2nd Oct 20237:00 amRNSResult of AGM
18th Sep 20235:30 pmRNSIssue of Equity and Total Voting Rights
7th Sep 20233:13 pmRNSHolding(s) in Company
7th Sep 20237:46 amRNSNotice of AGM
1st Sep 20234:49 pmRNSUpdate re AGM and Annual Report & Board Change
16th Aug 20234:01 pmRNSHolding(s) in Company
14th Aug 20233:04 pmRNSEquity Subscription and Total Voting Rights
9th Aug 20233:00 pmRNSExercise of Options
1st Aug 20237:00 amRNSAppointment of Chief Operating Officer
24th May 20237:00 amRNSTrading Update
4th May 20237:00 amRNSDirectorate Change
22nd Dec 20227:00 amRNSInterim Results
25th Nov 20225:05 pmRNSResult of Reconvened AGM
1st Nov 20227:00 amRNSBoard Changes
18th Oct 20228:24 amRNSNotice of General Meeting
30th Sep 202212:00 pmRNSResults for the year ended 31 March 2022
29th Sep 20227:00 amRNSResult of AGM
5th Sep 202211:00 amRNSNotice of Annual General Meeting
17th Aug 202210:00 amRNSAppointment of Don Haselton as GM of CMS Laser
29th Jul 20224:48 pmRNSExercise of Options and Total Voting Rights
10th Jun 20227:00 amRNSExercise of Options and Total Voting Rights
5th May 202211:03 amRNSHolding(s) in Company
11th Apr 20227:00 amRNSCompletion of Machine Tools Sale
24th Mar 20223:45 pmRNSResult of General Meeting
7th Mar 20229:05 amRNSSecond Price Monitoring Extn
7th Mar 20229:00 amRNSPrice Monitoring Extension
7th Mar 20227:00 amRNSProposed disposal of Machine Tool Solutions
28th Feb 20227:00 amRNSBoard Changes
15th Nov 20217:00 amRNSInterim Results
12th Nov 20217:00 amRNSTrading Update & Second Round PPP Loan Forgiveness
29th Sep 20217:00 amRNSResult of AGM
2nd Sep 20217:00 amRNSBoard Changes
2nd Sep 20217:00 amRNSResults for the year ended 31 March 2021
20th Jul 202111:05 amRNSSecond Price Monitoring Extn
20th Jul 202111:00 amRNSPrice Monitoring Extension
20th Jul 20217:00 amRNSTrading Update and Notice of Results
15th Jul 20217:00 amRNSSuccessful Loan Note Restructuring
15th Apr 202111:05 amRNSSecond Price Monitoring Extn
15th Apr 202111:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.